Skip to main content
Print Save

ZA08 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint ZA08 is White, Elliptical/Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Zydus Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA08

Divalproex sodium delayed-release 125 mg ZA08

Divalproex Sodium Delayed-Release

Imprint
ZA08
Strength
125 mg
Color
White
Size
12.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
National Drug Code (NDC)
68382-0031
Inactive Ingredients
ammonia, butyl alcohol, microcrystalline cellulose, ferrosoferric oxide, hypromelloses, isopropyl alcohol, magnesium stearate, methacrylic acid, polyethylene glycol, povidone, propylene glycol, shellac, silicon dioxide, sodium starch glycolate type A potato, corn starch, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer